Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma

Eriksson, Jule A.; Wanka, Christina; Burger, Michael C.; Urban, Hans; Hartel, Ines; von Renesse, Janusz; Harter, Patrick N.; Mittelbronn, Michel; Steinbach, Joachim P.; Rieger, Johannes

dc.contributor.author	Rieger, Johannes
dc.date.accessioned	2019-12-02T12:19:10Z
dc.date.available	2019-12-02T12:19:10Z
dc.date.issued	2018
dc.identifier.issn	1471-4159
dc.identifier.uri	http://hdl.handle.net/10900/95223
dc.language.iso	en	en
dc.publisher	Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/jnc.14264
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_03762
utue.publikation.seiten	421-430	de_DE
utue.personen.roh	Eriksson, Jule A.
utue.personen.roh	Wanka, Christina
utue.personen.roh	Burger, Michael C.
utue.personen.roh	Urban, Hans
utue.personen.roh	Hartel, Ines
utue.personen.roh	von Renesse, Janusz
utue.personen.roh	Harter, Patrick N.
utue.personen.roh	Mittelbronn, Michel
utue.personen.roh	Steinbach, Joachim P.
utue.personen.roh	Rieger, Johannes
dcterms.isPartOf.ZSTitelID	Journal of Neurochemistry	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	144	de_DE
utue.fakultaet	04 Medizinische Fakultät